Exceed Your Due Diligence and Control MSK Costs With the Regenexx Corporate Program
As a trusted advisor to self-funded employers, your responsibility is to deliver smarter healthcare strategies that dramatically lower costs and improve employee well-being. With musculoskeletal (MSK) conditions consistently dominating healthcare spend, offering a proven, evidence-based solution is no longer optional—it’s essential.
We empower you to fulfill this critical role and offer a solution that exceeds your due diligence. The Regenexx Corporate Program regularly helps partners achieve MSK spend cuts by 50% or more— directly impacting your clients’ bottom line and enhancing their benefits strategy. Read on to learn why there is no better interventional strategy to impact the cost of conservative care than a partnership with us.
Make Our Strengths Your Strategic Advantage: Seamless Onboarding, Revolutionary and Compliant MSK Care
Our team’s extensive experience, built from onboarding over 2,000 Corporate Program partners, becomes your advantage to ensure a seamless process from initial discovery through full benefit rollout. This streamlined implementation allows you to confidently introduce a game-changing solution to your self-funded clients.
The landscape of musculoskeletal (MSK) care is rapidly evolving, and Regenexx has led this charge with two decades of innovation and leadership. When you champion the Regenexx benefit, you’re not just offering another high-quality MSK option. You’re delivering a more cost-effective future for your clients and providing an MSK care solution their employees demonstrably prefer.
Our program delivers a high-value option for self-funded employers seeking a compliant, cost-saving option that passes the test for experimental and investigative procedures through key criteria including: safety, efficacy, and net clinical benefit. Partnering with the Regenexx Corporate Program allows you to offer a truly differentiated and impactful benefit.
The Regenexx Corporate Program regularly helps partners achieve MSK spend cuts by 50% or more — which often contributes to a reduction in total medical spend by up to 10%. Your clients’ MSK spend deserves a closer look from our team of experts who can help you evaluate the key areas driving cost and provide a second opinion on current strategies. Request a complimentary, comprehensive impact study that demonstrates the potential for MSK cost savings using your client’s own deidentified data.
NO COST & EASY FOR GROUPS TO ADD
The Regenexx benefit is always added at no cost to the health plan. Onboarding is as soon as 1 week pending TPA receiving SPD, onboarding form completion, benefit card text approval, and eligibility file received from TPA.
BROKER ASSISTANCE
Introductions to clients and prospects
PARTNER TO 100+ TPAs & ~100 STOP-LOSS CARRIERS
Partnerships to aid you and your clients
CLIENT MEETING MATERIALS
Resources to help inform your clients’ decisions to add the Regenexx benefit
*Timeframe to add Regenexx benefit depends on how quickly TPA receives SPD, onboarding form is completed, benefits card text is approved, and eligibility file is received from TPA.
Helping You Deliver More Value
Top 3 Reasons to Introduce Regenexx to your Clients
- Surgical alternative that integrates easily with existing plans
- Cost-containment strategy with proven data on claims reduction
- High-impact benefit that supports workforce productivity and satisfaction
Numbers That Differentiate Your Offering
Educate to Save: Utilization and Candidacy Drive Cost Control
The efficacy of even the most robust MSK solution hinges on employee awareness and engagement. Recognizing this, the Regenexx Corporate Program incorporates a turnkey member education strategy. This ensures employees and their families understand Regenexx as a high-quality, non-surgical option precisely when an MSK issue emerges.
Informed members who engage earlier in their care journey help drive substantial cost savings through the likelihood of surgical avoidance. Utilization review helps further ensure that patients with good candidacy ratings move forward with appropriate physician recommended care and supports cost savings by reducing unnecessary or inappropriate treatments. The utilization review process for benefit member care is founded in the clinical integrity and outcomes data of the Regenexx approach to candidacy.
This optimized utilization represents a tangible benefit brokers can confidently present and support. When members are informed, they engage earlier, avoid unnecessary surgeries, and drive real savings. It’s the kind of utilization that brokers can confidently stand behind.
We’re here to help.
Trusted by Leading U.S. Brokerage Firms to Reduce Healthcare Spend
